학술논문
Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis
Document Type
Article
Author
Ruminski, P.G.; Massa, M.; Strohbach, J.; Hanau, C.E.; Schmidt, M.; Scholten, J.A.; Fletcher, T.R.; Hamper, B.C.; Carroll, J.N.; Shieh, H.S.; Caspers, N.; Collins, B.; Grapperhaus, M.; Palmquist, K.E.; Collins, J.; Baldus, J.E.; Hitchcock, J.; Kleine, H.P.; Rogers, M.D.; McDonald, J.; Schnute, M.E.; Munie, G.E.; Sunyer, T.; Messing, D.M.; Portolan, S.; Whiteley, L.O.
Source
In: Journal of Medicinal Chemistry . (Journal of Medicinal Chemistry, 14 January 2016, 59(1):313-327)
Subject
Language
English
ISSN
15204804
00222623
00222623